Given the impacts of Aβ retention and APOE ε4 allele genotype on the increased functional activity of this ROI (Oh et al., 2014; Wang et al., 2015), further studies with these AD risk factors should be undertaken. The gene discussed is APOE; the disease is Alzheimer disease.